agilon health (NYSE: AGL) CEO receives 320,000 stock-based awards
Rhea-AI Filing Summary
O'Rourke Timothy Patrick reported acquisition or exercise transactions in this Form 4 filing.
agilon health, inc. CEO and President Timothy Patrick O'Rourke reported stock-based compensation awards rather than open-market trades. He received 200,000 shares of Common Stock as a grant on May 7, 2026, increasing his directly held Common Stock to 320,000 shares.
On the same date, he also received a separate 120,000-share award, bringing that holding to 120,000 shares. Footnotes explain that a portion consists of restricted stock units vesting in three equal installments starting on the anniversary of May 7, 2026, and performance stock units that may vest over a three-year period if 30‑trading‑day weighted average prices reach $50, $100 and $150, subject to continued employment.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 320,000 shares
Net Buy
2 txns
Insider
O'Rourke Timothy Patrick
Role
CEO & President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 120,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 200,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 320,000 shares (Direct)
Footnotes (3)
- F1. Restricted stock units that vest in three equal installments on each anniversary of May 7, 2026, subject to continued employment.
- F2. Includes restricted stock units.
- F3. Performance stock units may become vested subject to attainment during the three-year performance period (one-third vests if 30-trading-day weighted average price is equal or greater than $50, one-third vests if 30-trading-day weighted average price is equal or greater than $100, one-third vest if 30-trading-day weighted average price is equal or greater than $150) and continued employment through the end of such three-year performance period.
Key Figures
Time-based stock grant: 200,000 shares
Holdings after time-based grant: 320,000 shares
Performance stock award: 120,000 shares
+3 more
6 metrics
Time-based stock grant
200,000 shares
Common Stock grant on May 7, 2026
Holdings after time-based grant
320,000 shares
Common Stock directly held after 200,000-share grant
Performance stock award
120,000 shares
Separate Common Stock award on May 7, 2026
VWAP vesting hurdle 1
$50
30-trading-day weighted average price for first PSU tranche
VWAP vesting hurdle 2
$100
30-trading-day weighted average price for second PSU tranche
VWAP vesting hurdle 3
$150
30-trading-day weighted average price for final PSU tranche
Key Terms
Restricted stock units, Performance stock units, three-year performance period, 30-trading-day weighted average price, +1 more
5 terms
Restricted stock units financial
"Restricted stock units that vest in three equal installments on each anniversary of May 7, 2026, subject to continued employment."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance stock units financial
"Performance stock units may become vested subject to attainment during the three-year performance period..."
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
three-year performance period financial
"Performance stock units may become vested subject to attainment during the three-year performance period..."
30-trading-day weighted average price financial
"one-third vests if 30-trading-day weighted average price is equal or greater than $50..."
continued employment financial
"subject to continued employment through the end of such three-year performance period."
Continued employment means that an individual remains in their current job without interruption. For investors, it signals stability and ongoing work that can affect company performance and future prospects. Like a steady heartbeat for a business, sustained employment helps ensure consistent operations and financial health.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did agilon health (AGL) CEO report in this Form 4 filing?
The CEO, Timothy Patrick O'Rourke, reported stock-based compensation awards, not market trades. He received two grants of Common Stock on May 7, 2026, which increased his directly held and awarded share positions, subject to multi‑year vesting and performance conditions.
Are the agilon health (AGL) CEO’s new awards time-based restricted stock units?
Part of the CEO’s awards are restricted stock units that vest in three equal installments. Vesting occurs on each anniversary of May 7, 2026, and is conditioned on his continued employment with agilon health, creating a staggered, multi‑year compensation structure.
How do the agilon health (AGL) CEO’s performance stock units vest?
The performance stock units may vest over a three-year performance period if share-price hurdles are met. One-third vests at a 30‑day weighted average price of $50, another third at $100, and the final third at $150, all requiring continued employment through the period.
What type of ownership does the agilon health (AGL) CEO have for these awards?
The filing classifies the CEO’s ownership of these awards as direct. The reported positions and transactions are non‑derivative Common Stock, and footnotes indicate that they include restricted stock units and performance stock units with defined vesting and performance criteria.